Targeting the Tumor Stroma with Peroxisome Proliferator Activated Receptor (PPAR) Agonists

Publisher： Bentham Science Publishers

E-ISSN： 1875-5992|9|7|816-821

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.9, Iss.7, 2009-09, pp. : 816-821

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Use of the Peroxisome Proliferator-Activated Receptor (PPAR)  Ligand Troglitazone as Treatment for Refractory Breast Cancer: A Phase II Study

By Burstein H.J.  

Breast Cancer Research and Treatment, Vol. 79, Iss. 3, 2003-06 ,pp. : 391-397

Springer Publishing Company

Access to resources Recommend Favorite

microRNA-34a and microRNA-34c promote the activation of human hepatic stellate cells by targeting peroxisome proliferator-activated receptor γ

By  

Molecular Medicine Reports, Vol. 11, Iss. 2, 2015-01 ,pp. : 1017-1024

Spandidos Publications

Access to resources Recommend Favorite

The expression and role of peroxisome proliferator-activated receptor α in atherosclerosis

By      

Molecular Medicine Reports, Vol. 7, Iss. 3, 2013-01 ,pp. : 862-868

Spandidos Publications

Access to resources Recommend Favorite

Peroxisome Proliferator Activated Receptor-Gamma Ligands as Potent Antineoplastic Agents

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 3, Iss. 3, 2003-05 ,pp. : 239-251

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Peroxisome Proliferator-Activated Receptor-&ggr; in Breast Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 12, Iss. 9, 2012-11 ,pp. : 1025-1044

Bentham Science Publishers

Access to resources Recommend Favorite